Literature DB >> 31604902

Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma.

Mariana R Camacho1, Elba Etchebehere1,2, Natalia Tardelli3, Marcia T Delamain4, Aline F A Vercosa2, Maria E S Takahashi5, Sergio Q Brunetto6, Irene G H L Metze3,4, Cármino A Souza3,4, Juliano J Cerci7, Celso D Ramos8,2,3.   

Abstract

Quantification of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) can be time-consuming. We evaluated the performance of an automatic multifocal segmentation (MFS) method of quantification in patients with different stages of Hodgkin lymphoma, using the multiple VOI (MV) method as reference.
Methods: This prospective bicentric study included 50 patients with Hodgkin lymphoma who underwent staging 18F-FGD PET/CT. The examinations were centrally reviewed and processed with commercial MFS software to obtain MTV and TLG using 2 fixed relative thresholds (40% and 20% of SUVmax) for each lesion. All PET/CT scans were processed using the MV and MFS methods. Interclass correlation coefficients and Bland-Altman plots were used for statistical analysis. Repeated calculations of MTV and TLG values by 2 observers with different degrees of PET/CT imaging experience were used to ascertain interobserver agreement on the MFS method.
Results: The means and SDs obtained for the MTV with MV and MFS were, respectively, 736 ± 856 mL and 660 ± 699 mL for the 20% threshold and 313 ± 359 mL and 372 ± 434 mL for the 40% threshold. The time spent calculating the MTV was much shorter with the MFS method than with the MV method (median time, 11.6 min [range, 1-30 min] and 64.4 min [range, 1-240 min], respectively), especially in patients with advanced disease. Time spent was similar in patients with localized disease. There were no statistical differences between the MFS values obtained by the 2 different observers.
Conclusion: MTV and TLG calculations using MFS are reproducible, generate similar results to those obtained with MV, and are much less timing-consuming. Main differences between the 2 methods were related to difficulties in avoiding overlay of VOIs in the MV technique. MV and MFS perform equally well in patients with a small number of lesions.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET/CT; Hodgkin lymphoma; MTV; SUV; TLG; VOI

Mesh:

Substances:

Year:  2019        PMID: 31604902     DOI: 10.2967/jnmt.119.231118

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  2 in total

1.  Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?

Authors:  Philipp E Hartrampf; Marieke Heinrich; Anna Katharina Seitz; Joachim Brumberg; Ioannis Sokolakis; Charis Kalogirou; Andreas Schirbel; Hubert Kübler; Andreas K Buck; Constantin Lapa; Markus Krebs
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

2.  AuNP Aptasensor for Hodgkin Lymphoma Monitoring.

Authors:  Maria Slyusarenko; Sergey Shalaev; Alina Valitova; Lidia Zabegina; Nadezhda Nikiforova; Inga Nazarova; Polina Rudakovskaya; Maxim Vorobiev; Alexey Lezov; Larisa Filatova; Natalia Yevlampieva; Dmitry Gorin; Pavel Krzhivitsky; Anastasia Malek
Journal:  Biosensors (Basel)       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.